Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

NCT03596073 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
43
Enrollment
OTHER
Sponsor class

Stopped Interim analysis did not show the required cytokine induction by topical calcipotriene to justify continuation of the trial

Conditions

Interventions

Sponsor

Massachusetts General Hospital